Our first pan‐cancer analyses of MYL9 indicated statistical correlations of MYL9 expression with clinical prognosis, immune cell infiltration across multiple tumors, which aids in understanding the role of MYL9 in tumorigenesis from the perspective of clinical tumor samples. Here, MYL9 is linked to neoplasm.